Getting your player ready...
Clovis Oncology Inc., a Boulder-based company focused on acquiring, developing and commercializing anti-cancer agents, has secured $145 million in startup financing.
The company was founded by former executives of Pharmion Corp., which was acquired by Celgene Corp. in 2008 for $2.9 billion.
Investors include Domain Associates, New Enterprise Associates, Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures and ProQuest Investments.
